Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to determine the effects good or bad of combining
BEZ235 along with Everolimus to determine if it is a safe treatment for patients with
advanced cancers of different types.